Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gastrointestinal Cancer

Breast Cancer

Gastrointestinal Cancer

Expert Shares Insight on Navigating Neuroendocrine Tumor Treatment

Paul R. Helft, MD, discusses the incidence of gastrointestinal neuroendocrine tumors and available and emerging treatment methods.
Read More >>

Therapeutic Options Continue to Grow for HCC

AACR 2018: Epacadostat Falls Short Again

Role of Immunotherapies Emerging in Gastric/GEJ Cancers

HCC Trials Spur Treatment Landscape Forward

Tempero Spotlights Frontline Treatment Options in Pancreatic Cancer

View More Stories >>

View Conference Coverage

2018 AACR Annual Meeting

2018 European Lung Cancer Congress

2018 SGO Annual Meeting

2018 State of the Science Summit on Gastrointestinal Malignancies

2018 State of the Science Summit on Prostate Cancer

Dr. Kopetz Discusses the Treatment of BRAF-Mutant CRC

Dr. Bekaii-Saab on Napabucasin in Patients With Pancreatic Cancer

Dr. Bhoola on Enhanced Recovery After Surgery in Gynecologic Cancer

Dr. Van Loon Discusses the Management of Rectal Cancer

Dr. Shah on the Relationship Between H. Pylori and Immune Response in Gastric Cancer

Dr. Singh Discusses the Next Steps for Immunotherapy in GISTs

Dr. Helft Discusses Pancreatic and Carcinoid NETs

OncLive houses thousands of videos that provide updates and information.
See more Videos

$Immunotherapy Options in Refractory CRC$

Immunotherapy Options in Refractory CRC

Supportive Care in Metastatic CRC

Maintenance and Second-Line Decisions in CRC

Frontline Antibody Selection in Metastatic CRC

Role of Molecular Testing in CRC Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Outlook in Pancreatic Cancer

Promising New Therapies in Pancreatic Cancer

Pancreatic Cancer: Looking Beyond Second-Line Therapy

Immunotherapy in MSI-High Pancreatic Tumors

Developments in the NETs Treatment Landscape

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

Andrew Ko, MD, professor, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, provides insight on PEGPH20 for patients with pancreatic adenocarcinoma. View Now

Sequencing Decisions in Gastroesophageal Cancers

Led by Johanna Bendell, MD, panelists Ian Chau, MD; Yelena Y. Janjigian, MD; Manish A. Shah, MD; and Kohei Shitara, MD, focus on sequencing decisions for patients with gastroesophageal cancers. View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in RCC and Chronic ITP, 2018 ELCC Highlights, and More